Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2018 6
2019 5
2020 2
2021 4
2022 2
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy.
Mukha A, Kahya U, Linge A, Chen O, Löck S, Lukiyanchuk V, Richter S, Alves TC, Peitzsch M, Telychko V, Skvortsov S, Negro G, Aschenbrenner B, Skvortsova II, Mirtschink P, Lohaus F, Hölscher T, Neubauer H, Rivandi M, Labitzky V, Lange T, Franken A, Behrens B, Stoecklein NH, Toma M, Sommer U, Zschaeck S, Rehm M, Eisenhofer G, Schwager C, Abdollahi A, Groeben C, Kunz-Schughart LA, Baretton GB, Baumann M, Krause M, Peitzsch C, Dubrovska A. Mukha A, et al. Among authors: rivandi m. Theranostics. 2021 Jun 26;11(16):7844-7868. doi: 10.7150/thno.58655. eCollection 2021. Theranostics. 2021. PMID: 34335968 Free PMC article.
Dynamics of CXCR4 positive circulating tumor cells in prostate cancer patients during radiotherapy.
Klusa D, Lohaus F, Franken A, Baumbach M, Cojoc M, Dowling P, Linge A, Offermann A, Löck S, Hušman D, Rivandi M, Polzer B, Freytag V, Lange T, Neubauer H, Kücken M, Perner S, Hölscher T, Dubrovska A, Krause M, Kurth I, Baumann M, Peitzsch C. Klusa D, et al. Among authors: rivandi m. Int J Cancer. 2023 Jun 15;152(12):2639-2654. doi: 10.1002/ijc.34457. Epub 2023 Mar 13. Int J Cancer. 2023. PMID: 36733230
Paraoxonase 1 (PON1) and stroke; the dilemma of genetic variation.
Tajbakhsh A, Rezaee M, Rivandi M, Forouzanfar F, Afzaljavan F, Pasdar A. Tajbakhsh A, et al. Among authors: rivandi m. Clin Biochem. 2017 Dec;50(18):1298-1305. doi: 10.1016/j.clinbiochem.2017.08.001. Epub 2017 Aug 3. Clin Biochem. 2017. PMID: 28779954 Review.
Comparative analysis of EpCAM high-expressing and low-expressing circulating tumour cells with regard to their clonal relationship and clinical value.
Franken A, Kraemer A, Sicking A, Watolla M, Rivandi M, Yang L, Warfsmann J, Polzer BM, Friedl TWP, Meier-Stiegen F, Stoecklein NH, Dayan D, Riethdorf S, Mueller V, Pantel K, Koch A, Hartkopf AD, Krawczyk N, Ruckhaeberle E, Niederacher D, Fehm T, Neubauer H. Franken A, et al. Among authors: rivandi m. Br J Cancer. 2023 May;128(9):1742-1752. doi: 10.1038/s41416-023-02179-0. Epub 2023 Feb 23. Br J Cancer. 2023. PMID: 36823365 Free PMC article.
2q35-rs13387042 variant and the risk of breast cancer: a case-control study.
Nesaei A, Naderi Ghale-Noie Z, Khorshid Shamshiri A, Afzaljavan F, Rivandi M, Tajbakhsh A, Homaei Shandiz F, Pasdar A. Nesaei A, et al. Among authors: rivandi m. Mol Biol Rep. 2022 May;49(5):3549-3557. doi: 10.1007/s11033-022-07195-6. Epub 2022 Apr 20. Mol Biol Rep. 2022. PMID: 35445312
22 results